Today, we announced we have entered into an agreement to acquire @CardivaMedical. We look forward to welcoming the team and the VASCADE® family of vascular closure products to Haemonetics. https://t.co/3QITeQcggL
Cardiva Medical Announces First Patients Enrolled in The AMBULATE Same Day Discharge Study Using VASCADE MVP® - First Prospective Multi-Center Study Evaluating Same Day Discharge for Patients Undergoing Cardiac Ablation Procedures for Atrial Fibrillation. https://t.co/oGXsuYJzbD
In honor of #NationalDoctorsDay, we would like to express our gratitude to all the doctors out there on the front lines. Your sacrifices and continual dedication to your patients do not go unnoticed. Thank you for all that you do! #DoctorsDay#AppreciationPost
NEW: Austin-based molecular diagnostics co. @Asuragen develops Armored RNA Quant® SARS-CoV-2 Control for use in developing assays in response to #COVID19 pandemic. https://t.co/LVPa6wFlfb #coronavirus#diagnostics
Attention EP Fellows! Join us April 1 at #EPLive for training for transseptal, vascular closure and ICRT with Co-Directors
@andreanatalemd and @aalahmadmd! Think Transseptal Access to Vascular Closure! Register here: https://t.co/BX2UU7FBJs
We're hiring a Territory Manager in Oklahoma! If you're a top tier sales professional, click here to learn more and apply to join our team: https://t.co/DVwRScoZ1N
We are pleased to announce the appointment of Thomas A. West as President and CEO of Intersect ENT, effective 07/22/19. “I am excited to join the Intersect ENT team in our mission of transforming care in the ear, nose and throat specialty," said Mr. West. https://t.co/9uUepfaVri